Connect with us

Vaping & Vaporizing

48North Cannabis Corp. Ventures into US Market, Acquiring Quill Vape Tech Brand



48North Cannabis Corp. Ventures into US Market, Acquiring Quill Vape Tech Brand
- Ad -
  • 48North purchased Quill for just over $2 million.
  • This acquisition will allow 48North to get involved in both the cannabis and hemp industries in the US.

Canada made history when it legalized the use of recreational and medical marijuana throughout the entire country, and there are many companies already working to move into the US market as well. 48North Cannabis Corp. is one of the many dominant cannabis producers in Canada, and they signed a deal on Friday that allowed them to acquire Quill. Quill is a multi-state vape tech brand, and the deal closed for $2.1 million.

Quill has already established a distribution network in both Oregon in Washington, aiming to expand their efforts to California and Nevada. The majority of the focus for Quill is on vape pens that are easy to use, have a controlled dosage, and are disposable. The new deal will be fulfilled with a payment of $164,000 USD in cash, and $1.46 million USD in shares.

Vaping is becoming a popular pastime in the United States, and it has been a driving force behind the growing concentrate sales. One projection stated that the sale of concentrates will likely match the sale of flower by 2022 at $8.5 billion USD.

While Quill is involved in the vape technology side of the cannabis industry, it is not involved in the cultivation and distribution in the US cannabis market. Instead, the company focuses on offering the proprietary vape hardware to licensed processors. The processors then finish the products to distribute them in retail locations. The new deal will help 48North to increase their distribution of the products in the US, but it won’t open the door to ship its outdoor cannabis into the country.

As Quill emerges in the California market, there is an opportunity for 48North to grow even more with the booming recreational market. Vape products have gained a lot of traction in California, accounting for 30% of retail sales. The sale of flower beats out concentrates by only 2% more. Every product from Quill comes with full testing data as well, allowing their customers to ensure a safe and legal experience.

Though Quill’s focus primarily appears to be on the ability to bring in their vape technology, the company is also excited to dive into the hemp craze that is growing in the U.S. Their hemp-based full-spectrum CBD is available in a vape pen, and 48North plans to distribute more of these products in the US as it is legally allowed.

Alison Gordon, the co-CEO, said that it is necessary for 48North to use the acquisition of Quill to get involved in its network. She added,

“I believe that authentic brands and next-generation products distributed at scale, particularly in the emerging US market, will be one of the major keys to success in the cannabis industry.”

Andie Francese is a professional content consultant living in New York. In her copywriting career, as the leader of a group of award-winning journalists, Andrea was always gifted in organizing and optimizing teams of all sizes into creating and crafting valuable guides and insightful information into the topics presented to her acclaimed status. TOC is very excited to have her as part of our growing team.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.